phase i study of venetoclax plus daratumumab and dexamethasone, with or without bortezomib...
Published 3 years ago • 223 plays • Length 42:41Download video MP4
Download video MP3
Similar videos
-
2:48
bellini, a phase iii study of venetoclax or placebo in combination with bortezomib and dex in rrmm
-
2:51
bellini: venetoclax or placebo with bortezomib and dexamethasone for relapsed/refractory multipl...
-
2:27
ash 2018: dara velcade dex with or without venetoclax
-
4:26
phase 2 study of venetoclax plus carfilzomib and dexamethasone in patients with rr multiple myeloma
-
8:11
venetoclax with bortezomib/dexamethasone: phase 3 bellini results in r/r myeloma
-
2:26
updated results from bellini: venetoclax with bortezomib/dexamethasone
-
8:06
venetoclax with bortezomib and dexamethasone shows good response but higher risk of treatment re...
-
3:22
phase i/ii study of milademetan plus low-dose cytarabine with or without venetoclax in r/r aml
-
3:45
venetoclax with bortezomib and dexamethasone in relapsed/refractory multiple myeloma
-
1:02:14
a focus on small molecules in myeloma
-
1:46
does the vendd /- bortezomib combination represent a new treatment option for patients with rrmm?
-
40:39
overall survival with daratumumab, lenalidomide, and dexamethasone in previously treated mm (pollux)
-
1:28
clinical management of venetoclax in multiple myeloma
-
1:36
#mypath2path - dr. difeo
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
36:07
iach webinar series: anti-cd38 monoclonal antibodies in multiple myeloma
-
1:16:50
the 1st online master class in transplantation and hematology (math) - session 4
-
52:12
the 1st online master class in transplantation and hematology (math) - session 1
-
1:10
dr. shah on the role of venetoclax in multiple myeloma